Bimekizumab Lowers Uveitis Rates in Axial Spondyloarthritis ...Middle East

In patients with axial spondyloarthritis, bimekizumab — a dual interleukin-17A/F inhibitor — showed a lower incidence rate of uveitis, suggesting protective effects against acute anterior uveitis. Medscape Medical News

Hence then, the article about bimekizumab lowers uveitis rates in axial spondyloarthritis was published today ( Tuesday 27/08/2024 - 09:37 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bimekizumab Lowers Uveitis Rates in Axial Spondyloarthritis )

Also on site :

• Saudi Arabia threatens military action against Iran
• Taylor Frankie Paul brutally attacks Dakota Mortensen with chair in front of daughter in horrifying video
• ‘Big Little Lies’ Author Teases Sequel Book, ‘Big Little Truths,’ And Season 3 Plot: “A Time Jump Always Made Sense To Me”